TorPharm's abbreviated new drug application for a generic form of Hytrin (terazosin HCl), an Abbott drug used for the treatment of high blood pressure and benign prostatic hyperplasia, or BPH, received FDA approval. TorPharm will market the drug in 1 mg, 5 mg and 10 mg strengths.
COPYRIGHT 2001 Lebhar-Friedman, Inc.
COPYRIGHT 2001 Gale Group